Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

PURPOSE: We sought to identify features of patients with advanced non–small cell lung cancer (NSCLC) who achieve long-term response (LTR) to immune checkpoint inhibitors (ICI), and how these might differ from features predictive of short-term response (STR). EXPERIMENTAL DESIGN: We performed a multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thummalapalli, Rohit, Ricciuti, Biagio, Bandlamudi, Chaitanya, Muldoon, Daniel, Rizvi, Hira, Elkrief, Arielle, Luo, Jia, Alessi, Joao V., Pecci, Federica, Lamberti, Giuseppe, Di Federico, Alessandro, Hong, Lingzhi, Zhang, Jianjun, Heymach, John V., Gibbons, Don L., Plodkowski, Andrew J., Ravichandran, Vignesh, Donoghue, Mark T.A., Vanderbilt, Chad, Ladanyi, Marc, Rudin, Charles M., Kris, Mark G., Riely, Gregory J., Chaft, Jamie E., Hellmann, Matthew D., Vokes, Natalie I., Awad, Mark M., Schoenfeld, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618656/
https://www.ncbi.nlm.nih.gov/pubmed/37432985
http://dx.doi.org/10.1158/1078-0432.CCR-23-1207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618656/
https://www.ncbi.nlm.nih.gov/pubmed/37432985
http://dx.doi.org/10.1158/1078-0432.CCR-23-1207

Ejemplares similares